FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) is an exchange-traded fund that seeks to provide capital protection against declines in the S&P 500 Index during the period from approximately October 1 through September 30 of the following year, while offering participation in positive returns up to a specified cap. The fund employs a data-driven options strategy utilizing FLEX Options, which are customizable exchange-traded option contracts with standardized terms; it writes call options and purchases put options on the S&P 500 Index to create a deep buffer against the first 30% of losses in the reference index over the outcome period, subject to daily resets and management fees. DOCT forms part of the broader FT Vest suite of target outcome ETFs, including other monthly deep buffer funds such as those for January (BUFR), February (DFEB), and others through December, all managed by First Trust Advisors LP in partnership with Vest Financial LLC; these products target investors seeking defined-risk equity exposure, including financial advisors, retirement plans, and high-net-worth individuals primarily in the United States.
The fund operates exclusively within the U.S. equity market, with its investment objective tied to the performance of the S&P 500 Index; it was launched in 2022 and is domiciled in the United States, with First Trust Advisors LP headquartered in Wheaton, Illinois, serving as the sponsor and investment adviser. Vest Financial LLC, based in Chicago, Illinois, provides the quantitative model portfolio construction for the FT Vest buffer ETF complex, which collectively manages billions in assets under management as of late 2025.
In October 2025, FT Vest announced an expansion of its buffer ETF outcome periods to include enhanced cap potential for select share classes amid favorable volatility conditions; the firm also integrated DOCT into several new model portfolios distributed through leading wealth platforms like Envestnet and Orion Advisor Solutions, reflecting growing adoption in buffered outcome strategies. First Trust deepened its strategic alliance with Vest Financial through a renewed multi-year agreement in Q3 2025 to accelerate product innovation, including potential hybrid buffer-enhanced income variants. No major acquisitions, funding rounds, or name changes have occurred for DOCT or its managers within the last two years.